INVOcell Launched in Malaysia by Advanced Reproductive Centre, Hospital Canselor Tuanku Muhriz

Aug 25, 2022 | Press Releases

SARASOTA, Fla., Aug. 25, 2022 — INVO Bioscience, Inc. (Nasdaq: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell ® medical device and the intravaginal culture (“IVC”)...

INVO Bioscience Reports Second Quarter 2022 Financial Results

Aug 15, 2022 | Press Releases

Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla., Aug. 15, 2022 — INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a commercial-stage fertility company focused on expanding access to advanced treatment...

INVO Bioscience to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022

Aug 4, 2022 | Press Releases

Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET SARASOTA, Fla., Aug. 4, 2022 — INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment...

INVO Bioscience Announces “Get to Know INVOcell” – a Series of Facebook Live Events Supporting Access to Affordable Fertility Treatment

Jul 7, 2022 | Press Releases

Mark Your Calendars for July 7, 2022, with Dr. Sue Ellen Carpenter of Atlanta-based Bloom Fertility SARASOTA, Fla., July 7, 2022 — INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a commercial-stage fertility company...

INVO Signs Distribution Agreement with Onesky Holding Limited for Mainland China

May 16, 2022 | Press Releases

Agreement includes minimum purchase obligations upon product registration and approval SARASOTA, Fla., May 16, 2022 — INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a commercial-stage fertility company focused on...